Wayne T. Pan

Medical Director-Medical Sciences at BioMarin Pharmaceutical, Inc.

Wayne T. Pan

Wayne T. Pan

Medical Director-Medical Sciences at BioMarin Pharmaceutical, Inc.

Overview
RelSci Relationships

2184

Number of Boards

1

Birthday

1963

Age

57

Relationships
RelSci Relationships are individuals Wayne T. Pan likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Semler Scientific, Inc.

Relationship likelihood: Strong

Co-Founder at Semler Scientific, Inc.

Relationship likelihood: Strong

Chief Executive Officer, Secretary & Director at Semler Scientific, Inc.

Relationship likelihood: Strong

Chief Executive Officer & President at BioMarin Pharmaceutical, Inc.

Relationship likelihood: Strong

Officer & Senior Vice President at Guidant Sales Corp.

Relationship likelihood: Strong

Co-Founder at Health Advocate, Inc.

Relationship likelihood: Strong

Senior Managing Director at KCK Group LLC

Relationship likelihood: Strong

Managing Director at CBIZ, Inc.

Relationship likelihood: Strong

Founding Governor at The City Club of San Francisco, Inc.

Relationship likelihood: Strong

General Partner at First Guardian Group I LLC

Relationship likelihood: Strong

Paths to Wayne T. Pan
Potential Connections via
Relationship Science
You
Wayne T. Pan
Medical Director-Medical Sciences at BioMarin Pharmaceutical, Inc.
Education

The Wharton School is the business school of the University of Pennsylvania, an Ivy League university in Philadelphia, Pennsylvania. Wharton was the world’s first collegiate business school and the first business school in the United States. It was established in 1881 through a donation of Joseph Wharton.

To educate students, to foster independent & original research, and to share benefits discovered.

The School commits to dramatically advancing the art and science of medical care through an atmosphere of intense collaborative learning, social concern, and scholarly inquiry.

Career History
Medical Director-Medical Sciences
2018 - Current

About BioMarin BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises four approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; KUVAN® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany; and Firdapse™ (amifampridine phosphate), which has been approved by the European Commission for the treatment of Lambert Eaton Myasthenic Syndrome (LEMS). Product candidates include GALNS (N-acetylgalactosamine 6-sulfatase), which is currently in Phase III clinical development for the treatment of MPS IVA, PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is currently in Phase II clinical development for the treatment of PKU, BMN-701, a novel fusion protein of insulin-like growth factor 2 and acid alpha glucosidase (IGF2-GAA), which is currently in Phase I/II clinical development for the treatment of Pompe disease, and BMN-673, a poly ADP-ribose polymerase (PARP) inhibitor, which is currently in Phase I/II clinical development for the treatment of genetically-defined cancers and BMN-111, a modified C-natriuretic peptide, which is currently in Phase I clinical development for the treatment of achondroplasia.

Medical Director-Quality Care & Health Economics
2016 - 2018

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer, Kenneth B. Lee and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Medical Director
2014 - 2015
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Wayne T. Pan. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Wayne T. Pan's profile does not indicate a business or promotional relationship of any kind between RelSci and Wayne T. Pan.